Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease
NCT00780949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2012-08-03
Summary
The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U843 in collaboration with the department of immunology and statistics, Robert Debré Hospital.
Conditions
Interventions
- OTHER
-
intestinal biopsies
intestinal biopsies during routine endoscopy
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jean-Pierre HUGOT, Professeur · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- France
Study Locations
More Related Trials
-
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330 ·Status: COMPLETED
-
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
NCT06244849 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study
NCT06589895 ·Status: COMPLETED
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
NCT00707512 ·Status: TERMINATED
-
Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab
NCT00308581 ·Status: COMPLETED ·Phase: PHASE3
-
Pathogenic Study of Adult Immune Enteropathies
NCT04280510 ·Status: RECRUITING
-
Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis
NCT02549976 ·Status: COMPLETED ·Phase: NA
-
Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease
NCT01503099 ·Status: UNKNOWN
-
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
NCT07166588 ·Status: ENROLLING_BY_INVITATION
-
Disease Course in an IBD Cohort in the Era of Biological Treatment
NCT01468090 ·Status: COMPLETED
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Unveiling the Microbial Impact on Intestinal Fibrosis
NCT06073288 ·Status: NOT_YET_RECRUITING
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease
NCT02909244 ·Status: COMPLETED
-
Clinical Course of Korean Crohn's Disease Cohort
NCT01554007 ·Status: UNKNOWN
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease
NCT00333788 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease
NCT01891214 ·Status: COMPLETED
-
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
NCT05841537 ·Status: ACTIVE_NOT_RECRUITING
-
Search for New Genetic Mutations Major Effect in Crohn's Disease
NCT02851134 ·Status: COMPLETED
-
Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
NCT07167186 ·Status: NOT_YET_RECRUITING
-
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
NCT00160706 ·Status: COMPLETED ·Phase: PHASE3
-
Infliximab Blood Test in Crohn's Disease
NCT03964883 ·Status: COMPLETED